（文章来源：证券日报） 证券日报网讯 2月25日，维远股份在互动平台回答投资者提问时表示，公司严格遵守上市公司治理准 则，管理制度不断完善，生产经营正常平稳。 ...

证券日报网讯2月25日，维远股份（600955）在互动平台回答投资者提问时表示，公司锂电池电解液溶 剂约占同行业份额为6%，目前主要在国内销售，国外客户在开发中。公司25万吨/年电解液溶剂装置已 正式投产，2026年规划产能为25万吨。 ...

维远股份首次公开发行股票募集资金总额为40.65亿元，扣除发行费用后，募集资金净额为38.80亿元。 维远股份最终募集资金净额比原计划多20.01亿元，募投项目也较此前多一项。维远股份于2021年9月1 日披露的招股说明书显示，该公司拟募集资金金额为387,993.54万元，分别用于"35万吨/年苯酚、丙 酮、异丙醇联合项目""10万吨/年高纯碳酸二甲酯项目""研发中心项目""60万吨/年丙烷脱氢及40万吨/年 高性能聚丙烯项目""补充流动资金"。 中国经济网北京2月25日讯维远股份（600955）(600955.SH)今日股价下跌，截至收盘报20.89元，跌幅 1.69%。 维远股份于2021年9月15日在上交所主板上市，公开发行新股1.38亿股，发行价格为29.56元/股，保荐机 构、主承销商为中信证券股份有限公司，保荐代表人为黄超、李飞，联席主承销商为中泰证券 （600918）股份有限公司。该股目前处于破发状态。 维远股份首次公开发行股票发行费用为1.85亿元，其中，承销及保荐费用1.61亿元。 ...

格隆汇2月25日丨维远股份(600955.SH)在互动平台表示，公司锂电池电解液溶剂约占同行业份额为6% 左右，目前主要在国内销售，国外客户在开发中。公司25万吨/年电解液溶剂装置已正式投产，2026年 规划产能为25万吨。 ...

格隆汇2月25日丨维远股份(600955.SH)在互动平台表示，公司锂电池电解液溶剂约占同行业份额为6% 左右，目前主要在国内销售，国外客户在开发中。公司25万吨/年电解液溶剂装置已正式投产，2026年 规划产能为25万吨。 ...

关注公众号，点击公众号主页右上角" ··· "，设置星标 "⭐" ，关注 鑫椤锂电 资讯~ 本文来源：企业公告 维远股份2月2日公告， 公司25万吨/年电解液溶剂项目 近日打通全部流程，已顺利生产出合格产品。 该项目位于山东省东营市利津县，采用先进的新型、高效非均相催化工艺，以环氧丙烷和现有化工装置 副产的二氧化碳尾气等为原料，生产锂电池电解液用碳酸酯类溶剂产品，加速推动企业进入新能源领 域，同时实现二氧化碳减排和资源综合利用。 维远股份表示，本项目的投产，将使公司增加电子级碳酸丙烯酯、碳酸二甲酯、碳酸甲乙酯、碳酸二乙 酯产能，并副产丙二醇、食品级二氧化碳等产品。公司打造的"丙烷脱氢-环氧丙烷-电解液溶剂"新能 源产业链实现全链条贯通，产品结构更加丰富，进一步提高企业市场竞争力，促进企业的长远发展。 鑫椤报告预售： 2025-2029年中国电解液运行趋势及竞争策略研究报告 ICC 鑫椤资讯年终盘点： 2025年碳酸锂市场盘点： 2025年电解液市场盘点： 2025年铜箔市场盘点： 2025年钴酸锂市场盘点： 2025年三元材料市场盘点： 2025年磷酸铁锂市场盘点： 2025年三元前驱体市场盘点： 2025年 ...

Buyback Announcements - GoerTek has repurchased 1.14% of its shares, spending 1.108 billion yuan, with a total of 40.5481 million shares repurchased at prices ranging from 20.35 to 34.09 yuan per share [18] - Midea Group has repurchased 0.35% of its shares, spending 1.998 billion yuan, with a total of 26.9437 million shares repurchased at prices ranging from 69.50 to 80.44 yuan per share [17] - SF Holding has repurchased approximately 48.2887 million A-shares, with a total amount of about 1.899 billion yuan [1] Stock Trading Anomalies - Maoye Commercial has experienced a significant stock price increase, with a cumulative deviation of 20% over two trading days, indicating potential market overheating and high speculation risk [2] - Jinhui Liquor reported a cumulative stock price deviation of over 20% over three trading days, confirming normal production and no undisclosed major information [3] - Yangtze Optical Fiber has noted that the global optical fiber and cable market environment is normal, with new products related to data centers representing a small proportion of total demand [4] Profit Distribution Plans - Ningbo Fuda plans to distribute a cash dividend of 0.7 yuan per 10 shares, totaling 101 million yuan, which accounts for 59.85% of the net profit attributable to shareholders for the first three quarters of 2025 [5] Corporate Investments - Southwest Securities has received approval from the China Securities Regulatory Commission to issue bonds totaling up to 14 billion yuan [6] - Guoneng Rixin plans to increase its stake in Sanas Zhihui to 31% through an investment of 17.625 million yuan, enhancing its capabilities in new energy asset operation services [7] Production Updates - Weiyuan Co. has successfully launched a 250,000 tons/year electrolyte solvent project, enhancing its production capacity for various chemical products [8] Financial Performance - Lianyun Technology reported a net profit of 142 million yuan for 2025, a year-on-year increase of 20.36%, driven by growth in storage product demand [12] - Shanghai Yizhong reported a net profit of 64.132 million yuan for 2025, a significant increase of 819.42%, attributed to the inclusion of its core product in the national medical insurance directory [13]

Mergers and Acquisitions - Changling Hydraulic plans to acquire 12% of the company's shares at an offer price of 35.82 yuan per share [1] - Chip导科技 intends to purchase 100% equity of Jishun Technology for 403 million yuan and 17.15% equity of Shunlei Technology [2] Share Buybacks - Lexin Technology plans to repurchase shares worth between 50 million to 100 million yuan for employee stock ownership or equity incentives [3] - XGIMI Technology intends to repurchase shares worth between 50 million to 100 million yuan [3] - Lingyun Optical plans to change the purpose of 348.08 million shares for repurchase and cancel them [3] - Midea Group has spent 1.998 billion yuan to repurchase 0.35% of its shares [4] - GoerTek has spent 1.108 billion yuan to repurchase 1.14% of its shares [4] External Investments and Daily Operations - Weiyuan Co. has launched a 250,000 tons/year electrolyte solvent project [5] - Far East Co. signed contracts worth 3.075 billion yuan in January through its subsidiary [6] - Changchun Gaoxin's subsidiary GS3-007a has received approval for clinical trial application for a drug [7] - Aorui De plans to invest approximately 145 million yuan in purchasing computing power equipment to provide services to clients [7] - Electric Power Water Power intends to raise funds not exceeding 3.604 billion yuan through acquisition loans [7] - Guoneng Rixin plans to increase investment of 17.625 million yuan in controlling Sanas Zhihui to enhance new energy asset operation service capabilities [7] - Science plans to engage in molybdenum processing and sales to secure a stable resource supply for rhenium recycling [7] - Panlong Pharmaceutical has received approval for clinical trials of the drug Fluorobiphenyl Patch [8] - Hongxiang Co. plans to transfer 100% equity of Nantong Hanlan New Energy for 120 million yuan [9] - Daon Co. intends to acquire equity in a Vietnamese company for a total purchase price of approximately 15.737 million USD [10] Performance Changes - Shanghai Yizhong expects a net profit of 64.132 million yuan in 2025, a year-on-year increase of 819.42%, with its core product, injectable paclitaxel polymer micelles, included in the national medical insurance directory [11] - Lianyun Technology anticipates a 20.36% year-on-year increase in net profit in 2025, driven by growth in data storage main control chips [12]

Group 1 - Far East Holdings announced that its subsidiary won a contract order worth 3.075 billion yuan, including contracts for green building cables and smart manufacturing cables [1] - Yifan Pharmaceutical received a drug registration certificate for Vitamin K1 injection, which is used to treat vitamin K deficiency-related bleeding [2] - Guangdong Electric Power A's Maoming Bohua Power Plant's Unit 4 has successfully commenced commercial operation, with a total investment of 7.484 billion yuan and an expected annual power generation of 8.6 billion kWh [4] Group 2 - Longfly Fiber reported that the global fiber optic cable industry market environment is normal, with product price fluctuations needing comprehensive assessment [25] - Shanghai Yizhong's net profit for 2025 increased by 819.42%, with total revenue of 317 million yuan, a growth of 82.72% [22] - Guizhou Power's subsidiary received a government subsidy of 200 million yuan [8] Group 3 - Zhongxing Communications plans to invest 117 million yuan in the Jianxing Zhanlu Fund, which focuses on new information technology and advanced manufacturing [10] - Suwen Electric Power's subsidiary established a joint investment fund with a total commitment of 68.5 million yuan, with Suwen contributing 5 million yuan [26] - ST Kaiyuan announced that its stock may face delisting risk due to expected negative net assets for 2025 [27]

利华益维远化学股份有限公司 关于25万吨/年电解液溶剂项目的投产公告 本项目的投产，将使公司增加电子级碳酸丙烯酯、碳酸二甲酯、 碳酸甲乙酯、碳酸二乙酯产能，并副产丙二醇、食品级二氧化碳等产 品。公司打造的"丙烷脱氢-环氧丙烷-电解液溶剂"新能源产业链实 现全链条贯通，产品结构更加丰富，进一步提高企业市场竞争力，促 进企业的长远发展。 证券代码：600955 证券简称：维远股份 公告编号：2026-005 本公司及董事会全体成员保证本公告内容不存在虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 利华益维远化学股份有限公司（以下简称"公司"）25 万吨/年电 解液溶剂项目于近日打通全部流程，已顺利生产出合格产品。 一、项目基本情况 2022 年 12 月 9 日，公司召开了 2022 年第一次临时股东大会（决 议公告：2022-069），审议通过了《关于投资建设 25 万吨/年电解液溶 剂项目的议案》（详情请见公告：2022-064）。公司投资建设了 25 万吨 /年电解液溶剂装置，并配套建设了相应公用工程，近日打通全部流程， 全面投产并生产出合格产品。 二、项目对公司 ...